Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2016, Article ID 4358292, 6 pages
http://dx.doi.org/10.1155/2016/4358292
Research Article

GSTP1 Methylation and Protein Expression in Prostate Cancer: Diagnostic Implications

1Biosciences Laboratory, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Via P. Maroncelli 40, 47014 Meldola, Italy
2University of Florence, 50121 Florence, Italy
3Pathology Unit, Morgagni-Pierantoni Hospital, 47121 Forlì, Italy
4Department of Urology, Morgagni-Pierantoni Hospital, 47121 Forlì, Italy
5Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Via P. Maroncelli 40, 47014 Meldola, Italy
6Unit of Biostatistics and Clinical Trials, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Via P. Maroncelli 40, 47014 Meldola, Italy

Received 17 February 2016; Revised 21 June 2016; Accepted 3 July 2016

Academic Editor: Carmen Jeronimo

Copyright © 2016 Filippo Martignano et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [15 citations]

The following is the list of published articles that have cited the current article.

  • Kexin Xu, “DNA and Histone Methylation in Prostate Cancer,” DNA and Histone Methylation as Cancer Targets, pp. 489–529, 2017. View at Publisher · View at Google Scholar
  • Shaoxuan Wu, Lifeng Li, Yanyan Chi, Xianfei Ding, Wenhua Xue, Xinya Gao, Xueliang Zhou, Zhirui Fan, Tongwen Sun, Jie Zhao, Liuxing Wang, Mengmeng Dou, Zhuan Lü, and Weijie Zhang, “Methylation of gstp 1 gene promoter and the risk of prostate cancer: A meta-Analysis,” Tumor, vol. 37, no. 6, pp. 604–615, 2017. View at Publisher · View at Google Scholar
  • Pedro Gonzalez-Menendez, David Hevia, Juan C. Mayo, and Rosa M. Sainz, “The dark side of glucose transporters in prostate cancer: Are they a new feature to characterize carcinomas?,” International Journal of Cancer, 2017. View at Publisher · View at Google Scholar
  • Jason Gandhi, Adil Afridi, Sohrab Vatsia, Gargi Joshi, Gunjan Joshi, Steven A. Kaplan, Noel L. Smith, and Sardar Ali Khan, “The molecular biology of prostate cancer: current understanding and clinical implications,” Prostate Cancer and Prostatic Diseases, 2017. View at Publisher · View at Google Scholar
  • Duojia Wu, Jie Ni, Julia Beretov, Paul Cozzi, Mark Willcox, Valerie Wasinger, Bradley Walsh, Peter Graham, and Yong Li, “Urinary biomarkers in prostate cancer detection and monitoring progression,” Critical Reviews in Oncology/Hematology, vol. 118, pp. 15–26, 2017. View at Publisher · View at Google Scholar
  • Anshika N Singh, and Neeti Sharma, “Identification of key pathways and genes with aberrant methylation in prostate cancer using bioinformatics analysis.,” OncoTargets and therapy, vol. 10, pp. 4925–4933, 2017. View at Publisher · View at Google Scholar
  • Samanta Salvi, Valentina Casadio, Filippo Martignano, Giorgia Gurioli, Maria Maddalena Tumedei, Daniele Calistri, Roberta Gunelli, and Matteo Costantini, “Carcinosarcoma of the prostate: case report with molecular and histological characterization,” The International Journal of Biological Markers, pp. 172460081879146, 2018. View at Publisher · View at Google Scholar
  • Khaoula Hadami, Nadia Dakka, Mounia Bensaid, Hajar El Ahanidi, Ahmed Ameur, Hafsa Chahdi, Mohamed Oukabli, Abderrahmane Al Bouzidi, Mohammed Attaleb, and Mohammed El Mzibri, “Evaluation of glutathione S-transferase pi 1 expression and gene promoter methylation in Moroccan patients with urothelial bladder cancer,” Molecular Genetics & Genomic Medicine, 2018. View at Publisher · View at Google Scholar
  • Tieshi Liu, Rong Yang, Hongqian Guo, Xuefeng Qiu, Xiaozhi Zhao, Huibo Lian, Feng Qu, and Xiaogong Li, “Hypermethylation of the SPARC promoter and its prognostic value for prostate cancer,” Oncology Reports, vol. 39, no. 2, pp. 659–666, 2018. View at Publisher · View at Google Scholar
  • Antonio Gómez-Martín, Luis J. Martinez-Gonzalez, Ignacio Puche-Sanz, Jose M. Cozar, Jose A. Lorente, Antonio F. Hernández, and Maria J. Alvarez-Cubero, “GSTM1 gene expression and copy number variation in prostate cancer patients—Effect of chemical exposures and physical activity,” Urologic Oncology: Seminars and Original Investigations, 2018. View at Publisher · View at Google Scholar
  • Giorgia Gurioli, “Epigenetic Characterization of Cell-Free DNA,” Cell-free DNA as Diagnostic Markers, vol. 1909, pp. 129–135, 2018. View at Publisher · View at Google Scholar
  • Giorgia Gurioli, Filippo Martignano, Samanta Salvi, Matteo Costantini, Roberta Gunelli, and Valentina Casadio, “GSTP1 methylation in cancer: a liquid biopsy biomarker?,” Clinical Chemistry and Laboratory Medicine (CCLM), no. 0, 2018. View at Publisher · View at Google Scholar
  • Xiaojia Liu, Rong Zhu, Liping Zou, Ning Tan, Guangdong Pan, Hongguang Zhu, Hongtao Liao, Qing Xu, and Songqing He, “High GSTP1 inhibits cell proliferation by reducing Akt phosphorylation and is associated with a better prognosis in hepatocellular carcinoma,” Oncotarget, vol. 9, no. 10, pp. 8957–8971, 2018. View at Publisher · View at Google Scholar
  • Klara Cervena, Pavel Vodicka, and Veronika Vymetalkova, “Diagnostic and prognostic impact of cell-free DNA in human cancers: systematic review,” Mutation Research/Reviews in Mutation Research, 2019. View at Publisher · View at Google Scholar
  • Jie Zhang, Zhi-wei Ye, Danyelle M. Townsend, Chanita Hughes-Halbert, and Kenneth D. Tew, “Racial disparities, cancer and response to oxidative stress,” 2019. View at Publisher · View at Google Scholar